Shaanxi Panlong Pharmaceutical Group (SZSE:002864) 3-Year EBITDA Growth Rate : 9.40% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shaanxi Panlong Pharmaceutical Group 3-Year EBITDA Growth Rate?

Shaanxi Panlong Pharmaceutical Group's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.35.

During the past 12 months, Shaanxi Panlong Pharmaceutical Group's average EBITDA Per Share Growth Rate was -5.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shaanxi Panlong Pharmaceutical Group was 17.10% per year. The lowest was 2.90% per year. And the median was 9.40% per year.

Competitive Comparison of Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate falls into.

Shaanxi Panlong Pharmaceutical Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shaanxi Panlong Pharmaceutical Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shaanxi Panlong Pharmaceutical Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shaanxi Panlong Pharmaceutical Group Ltd (SZSE:002864) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

2801 Baliu 2nd Road, Modern Textile Ind Park Baqiao, Xian, CHN, 710025

Website

http://www.pljt.com

Shaanxi Panlong Pharmaceutical Group Ltd operates as a pharmaceuticals company. It manufactures and markets drugs for the treatment of traumatology, cardiovascular and cerebrovascular, respiratory, pediatrics, and hepatobiliary.

Executives

Zhang De Zhu	Directors, executives
Liu Zhao	Supervisors
Jian Bao Liang	Supervisors
Zhang Zhi Hong	Directors, executives
Zhang Shui Ping	Director
Wu Jie	Directors, Directors, and Executives
Zhu Feng Ming	Executives
Zhu Wen Feng	Director
Xie Xiao Feng	Director
Xie Xiao Lin	Directors, executives

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Headlines

No Headlines